You are here

Article Text

Article menu

Download PDFPDF

At a glance
Highlights from this issue
Free
  1. Keith Barton1,
  2. James Chodosh2,
  3. Jost B Jonas, Editors in chief3
  1. 1 Moorfields Eye Hospital, London, UK
  2. 2 Ophthalmology, Massachusetts Eye and Ear Infirmary Howe Laboratory Harvard Medical School, Boston, Massachusetts, USA
  3. 3 Ruprecht-Karls-University Heidelberg, Seegartenklinik Heidelberg, Department of Ophthalmology, Mannheim, Germany
  1. Correspondence to Keith Barton, Moorfields Eye Hospital, London, UK; BJO{at}keithbarton.co.uk

https://doi.org/10.1136/bjophthalmol-2020-318350

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan (see page 1647)

    In a nationwide survey in Japan, most ophthalmic facilities examined for HTLV-1 infection when considering he differential diagnoses for uveitis. Providing information on HTLV-1 infection to ophthalmologists has been successfully implemented over recent decades.

    Vision loss in anterior uveitis (see page 1652)

    In 2526 eyes with anterior uveitis, the incidence of permanent visual loss was 0.006/eye-year with a cumulative 10-year risk of 6.6% (5.2-8.4%). Uveitic glaucoma was the most common cause of vision loss.

    Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends, and projections (see page 1658)

    Approximately 22 million Africans have poor distance vision and an additional 101 million have poor near vision or presbyopia. The main causes are the easily treatable cataract and under-correction of refractive error. Glaucoma, age related macular degeneration and diabetic retinopathy are on the increase.

    Retrospective cohort study of severe dysfunctional tear syndrome patients and resolution of central corneal staining (see page 1669)

    The authors report that 88% of severe dry eye patients achieved a significant improvement in corneal epitheliopathy after an average of 4 years of treatment. Autoimmune disease and …

    View Full Text

    Linked Articles